106 related articles for article (PubMed ID: 22033286)
1. Control of metabolism by nutrient-regulated nuclear receptors acting in the brain.
Bantubungi K; Prawitt J; Staels B
J Steroid Biochem Mol Biol; 2012 Jul; 130(3-5):126-37. PubMed ID: 22033286
[TBL] [Abstract][Full Text] [Related]
2. Orphan nuclear receptors and the regulation of nutrient metabolism: understanding obesity.
Pearen MA; Muscat GE
Physiology (Bethesda); 2012 Jun; 27(3):156-66. PubMed ID: 22689791
[TBL] [Abstract][Full Text] [Related]
3. Natural compounds regulate energy metabolism by the modulating the activity of lipid-sensing nuclear receptors.
Goto T; Kim YI; Takahashi N; Kawada T
Mol Nutr Food Res; 2013 Jan; 57(1):20-33. PubMed ID: 23180608
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis.
Hansen MK; Connolly TM
Curr Opin Investig Drugs; 2008 Mar; 9(3):247-55. PubMed ID: 18311660
[TBL] [Abstract][Full Text] [Related]
5. Brain insulin signalling in the regulation of energy balance and peripheral metabolism.
Diamant M
Ideggyogy Sz; 2007 Mar; 60(3-4):97-108. PubMed ID: 17451048
[TBL] [Abstract][Full Text] [Related]
6. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
[TBL] [Abstract][Full Text] [Related]
7. Rice protein isolate improves lipid and glucose homeostasis in rats fed high fat/high cholesterol diets.
Ronis MJ; Badeaux J; Chen Y; Badger TM
Exp Biol Med (Maywood); 2010 Sep; 235(9):1102-13. PubMed ID: 20667909
[TBL] [Abstract][Full Text] [Related]
8. Cow's milk increases the activities of human nuclear receptors peroxisome proliferator-activated receptors alpha and delta and retinoid X receptor alpha involved in the regulation of energy homeostasis, obesity, and inflammation.
Suhara W; Koide H; Okuzawa T; Hayashi D; Hashimoto T; Kojo H
J Dairy Sci; 2009 Sep; 92(9):4180-7. PubMed ID: 19700678
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
Smith AG; Muscat GE
Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
[TBL] [Abstract][Full Text] [Related]
10. The nuclear receptor REV-ERBα is required for the daily balance of carbohydrate and lipid metabolism.
Delezie J; Dumont S; Dardente H; Oudart H; Gréchez-Cassiau A; Klosen P; Teboul M; Delaunay F; Pévet P; Challet E
FASEB J; 2012 Aug; 26(8):3321-35. PubMed ID: 22562834
[TBL] [Abstract][Full Text] [Related]
11. Gluten-free diet reduces adiposity, inflammation and insulin resistance associated with the induction of PPAR-alpha and PPAR-gamma expression.
Soares FL; de Oliveira Matoso R; Teixeira LG; Menezes Z; Pereira SS; Alves AC; Batista NV; de Faria AM; Cara DC; Ferreira AV; Alvarez-Leite JI
J Nutr Biochem; 2013 Jun; 24(6):1105-11. PubMed ID: 23253599
[TBL] [Abstract][Full Text] [Related]
12. High expression of liver histone deacetylase 3 contributes to high-fat-diet-induced metabolic syndrome by suppressing the PPAR-γ and LXR-α-pathways in E3 rats.
Li D; Wang X; Ren W; Ren J; Lan X; Wang F; Li H; Zhang F; Han Y; Song T; Holmdahl R; Lu S
Mol Cell Endocrinol; 2011 Sep; 344(1-2):69-80. PubMed ID: 21763752
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.
Beaven SW; Tontonoz P
Annu Rev Med; 2006; 57():313-29. PubMed ID: 16409152
[TBL] [Abstract][Full Text] [Related]
14. PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia.
Hennuyer N; Tailleux A; Torpier G; Mezdour H; Fruchart JC; Staels B; Fiévet C
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1897-902. PubMed ID: 15994444
[TBL] [Abstract][Full Text] [Related]
15. Sex-specific differences in Type 2 Diabetes Mellitus and dyslipidemia therapy: PPAR agonists.
Benz V; Kintscher U; Foryst-Ludwig A
Handb Exp Pharmacol; 2012; (214):387-410. PubMed ID: 23027460
[TBL] [Abstract][Full Text] [Related]
16. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver.
Anderson SP; Dunn C; Laughter A; Yoon L; Swanson C; Stulnig TM; Steffensen KR; Chandraratna RA; Gustafsson JA; Corton JC
Mol Pharmacol; 2004 Dec; 66(6):1440-52. PubMed ID: 15371561
[TBL] [Abstract][Full Text] [Related]
17. PPAR dual agonists: are they opening Pandora's Box?
Balakumar P; Rose M; Ganti SS; Krishan P; Singh M
Pharmacol Res; 2007 Aug; 56(2):91-8. PubMed ID: 17428674
[TBL] [Abstract][Full Text] [Related]
18. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
19. Preventive and ameliorating effects of citrus D-limonene on dyslipidemia and hyperglycemia in mice with high-fat diet-induced obesity.
Jing L; Zhang Y; Fan S; Gu M; Guan Y; Lu X; Huang C; Zhou Z
Eur J Pharmacol; 2013 Sep; 715(1-3):46-55. PubMed ID: 23838456
[TBL] [Abstract][Full Text] [Related]
20. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro A
Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
